

					

						November 28, 2017 - By Louis Casey
Barclays Plc decreased its stake in Bristol Myers Squibb Co (Call) (BMY) by 10.3% based on its latest 2017Q2 regulatory filing with the SEC. Barclays Plc sold 44,500 shares as the company’s stock declined 1.04% while stock markets rallied. The institutional investor held 387,700 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $21.60M, down from 432,200 at the end of the previous reported quarter. Barclays Plc who had been investing in Bristol Myers Squibb Co (Call) for a number of months, seems to be less bullish one the $102.39 billion market cap company. The stock rose 1.54% or $0.95 reaching $62.56. About 1.68 million shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since November 28, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.Harding Loevner Lp increased its stake in Hsbc Hldgs Plc (HSBC) by 7.14% based on its latest 2017Q2 regulatory filing with the SEC. Harding Loevner Lp bought 145,819 shares as the company’s stock declined 1.28% while stock markets rallied. The hedge fund held 2.19 million shares of the savings institutions company at the end of 2017Q2, valued at $101.50 million, up from 2.04 million at the end of the previous reported quarter. Harding Loevner Lp who had been investing in Hsbc Hldgs Plc for a number of months, seems to be bullish on the $197.77B market cap company. The stock rose 0.78% or $0.39 reaching $49.45 per share. About 866,295 shares traded. HSBC Holdings plc (ADR) (NYSE:HSBC) has risen 38.28% since November 28, 2016 and is uptrending. It has outperformed by 21.58% the S&P500.More news for HSBC Holdings plc (ADR) (NYSE:HSBC) were recently published by: Investorplace.com, which released: “Robust Earnings Momentum Make HSBC Holdings plc Sponsored ADR (HSBC) a Buy” on November 14, 2017. Investorplace.com‘s article titled: “Quant Score Keeps HSBC Holdings plc Sponsored ADR (HSBC) a Buy” and published on November 21, 2017 is yet another important article.Harding Loevner Lp, which manages about $36.30B and $16.33 billion US Long portfolio, decreased its stake in Facebook Inc (NASDAQ:FB) by 56,305 shares to 1.29M shares, valued at $195.05M in 2017Q2, according to the filing. It also reduced its holding in Priceline Grp Inc (NASDAQ:PCLN) by 8,152 shares in the quarter, leaving it with 195,096 shares, and cut its stake in Roper Technologies Inc (NYSE:ROP). Among 11 analysts covering HSBC Holdings (NYSE:HSBC), 3 have Buy rating, 2 Sell and 6 Hold. Therefore 27% are positive. HSBC Holdings had 19 analyst reports since September 30, 2015 according to SRatingsIntel. The stock has “Underweight” rating by Morgan Stanley on Monday, February 8. As per Thursday, March 24, the company rating was downgraded by Bank of America. JP Morgan upgraded HSBC Holdings plc (ADR) (NYSE:HSBC) on Monday, June 27 to “Neutral” rating. BNP Paribas upgraded the shares of HSBC in report on Thursday, January 19 to “Outperform” rating. UBS upgraded the shares of HSBC in report on Wednesday, September 30 to “” rating. BNP Paribas upgraded the shares of HSBC in report on Monday, June 27 to “Neutral” rating. UBS downgraded the shares of HSBC in report on Wednesday, September 14 to “Neutral” rating. As per Monday, November 21, the company rating was upgraded by Bernstein. BNP Paribas downgraded the shares of HSBC in report on Tuesday, March 29 to “Underperform” rating. The rating was upgraded by Morgan Stanley to “Equal-Weight” on Tuesday, December 6.Barclays Plc, which manages about $93.36 billion US Long portfolio, upped its stake in Becton Dickinson &Amp Co (Put) (NYSE:BDX) by 18,700 shares to 23,700 shares, valued at $4.62M in 2017Q2, according to the filing. It also increased its holding in Esterline Technologies Corp (NYSE:ESL) by 30,073 shares in the quarter, for a total of 39,272 shares, and has risen its stake in Veeva Sys Inc (NYSE:VEEV). More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: Seekingalpha.com which released: “Bristol-Myers Squibb (BMY) Presents at Jefferies 2017 London Healthcare …” on November 15, 2017, also Businesswire.com with their article: “European Medicines Agency Validates Bristol-Myers Squibb’s Type II Variation …” published on November 28, 2017, Investorplace.com published: “Anemic Quant Score Restrict Bristol-Myers Squibb Co (BMY) Rating” on November 24, 2017. More interesting news about Bristol-Myers Squibb Co (NYSE:BMY) were released by: Economictimes.Indiatimes.com and their article: “Biocon arm widens partnership terms with Bristol-Myers Squibb” published on November 14, 2017 as well as Nasdaq.com‘s news article titled: “Madrona Financial Services, LLC Buys ONEOK Inc, Boeing Co, Bristol-Myers …” with publication date: November 09, 2017.Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.03, from 0.98 in 2017Q1. It dropped, as 78 investors sold BMY shares while 520 reduced holdings. 120 funds opened positions while 451 raised stakes. 1.10 billion shares or 2.26% less from 1.12 billion shares in 2017Q1 were reported. Kimelman & Baird Lc stated it has 0.5% in Bristol-Myers Squibb Co (NYSE:BMY). Tompkins Financial Corporation holds 0.07% or 5,153 shares. 12,543 were accumulated by Symphony Asset Mngmt Ltd Llc. Spc Financial has invested 0.05% in Bristol-Myers Squibb Co (NYSE:BMY). Teacher Retirement Sys Of Texas holds 765,531 shares. Natl Bank Of Nova Scotia stated it has 0.26% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Private Asset Mgmt Inc holds 191,728 shares or 1.72% of its portfolio. Aviance Mgmt has invested 0.14% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). 11,492 were accumulated by Stonebridge Cap Mgmt. Peregrine Asset Advisers has invested 2.88% in Bristol-Myers Squibb Co (NYSE:BMY). Fcg Advisors Ltd stated it has 5,938 shares or 0.11% of all its holdings. 11.16M were accumulated by Invesco Ltd. Macnealy Hoover Invest reported 17,102 shares. Moreover, Putnam Invests Lc has 0.12% invested in Bristol-Myers Squibb Co (NYSE:BMY). Wendell David Associates holds 0.16% or 15,611 shares in its portfolio.Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. On Wednesday, October 18 the stock rating was maintained by Citigroup with “Buy”. The stock has “Hold” rating by Cowen & Co on Thursday, October 19. Jefferies maintained Bristol-Myers Squibb Co (NYSE:BMY) on Tuesday, June 14 with “Hold” rating. The firm earned “Neutral” rating on Friday, October 27 by Credit Suisse. UBS maintained Bristol-Myers Squibb Co (NYSE:BMY) on Friday, April 29 with “Buy” rating. The firm has “Equal-Weight” rating given on Friday, September 9 by Barclays Capital. The rating was maintained by Jefferies with “Buy” on Friday, September 15. Cowen & Co maintained Bristol-Myers Squibb Co (NYSE:BMY) rating on Monday, September 18. Cowen & Co has “Hold” rating and $65.0 target. UBS maintained it with “Buy” rating and $72.0 target in Friday, October 6 report. The firm earned “Hold” rating on Monday, July 17 by Deutsche Bank.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading